ESC 365 - Effects of guideline directed medical therapy on secondary mitral regurgitation

ESC Professional Premium Access

Effects of guideline directed medical therapy on secondary mitral regurgitation

Session: Secondary valvular regurgitation: classification, prognosis and intervention

Topic: Pharmacotherapy

Speaker: Mr G. Spinka (Vienna, AT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Georg Spinka

Medical University of Vienna, Vienna (Austria)

0 follower

5 more presentations in this session

Supervised learning-derived tailored risk-stratification in patients with severe secondary mitral regurgitation

Speaker: Doctor G. Heitzinger (Vienna, AT)

Impact of left ventricular contractility on mitral annular motion in an acute animal model

Speaker: Doctor R. Persson (Bergen, NO)

A preliminary analysis regarding functional mitral regurgitation grading with echocardiography and CMR: in search of similarities and resolving discordances.

Speaker: Doctor S. Maltes (Lisbon, PT)

Influence of pacemaker leads on the severity of tricuspid regurgitation after successful mitral valve edge to edge repair

Speaker: Mr M. Alsaad (Bielefeld, DE)

Utility and futility of MitraClip implantation in secondary mitral regurgitation in a real-world population: the role of 3D transthoracic echocardiography.

Speaker: Doctor V. Mantegazza (Milan, IT)

Access the full session

Secondary valvular regurgitation: classification, prognosis and intervention

Speakers: Mr G. Spinka, Doctor G. Heitzinger, Doctor R. Persson, Doctor S. Maltes, Mr M. Alsaad...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources